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Historical Developments and Perspectives
in Inorganic Fiber Toxicity in Man
by Irving J. Selikoff*
The first patient known to have died from asbestosis (1900) began work in 1885, approximately 5 years
after the industrial use ofasbestos began in Britain. Mineral particles were found in his lungs. No special
comment was made oftheir fibrous nature then nor when the first case was reported in 1924. The various
neoplasms attributed to asbestos in the next decades posed an additional question: What influence did the
fibrous shape of the particles have on carcinogenic potential? The cogency ofthe problem was amplified
by the identification in humans of asbestoslike neoplasms with a fiber other than asbestos (erionite) and
by the production ofsuch neoplasms in experimental animals with avariety ofman-made inorganic fibers,
often used as substitutes for asbestos. The lessons learned about asbestos may help guide us in evaluating
current fiber problems.
Introduction
The first recorded case ofasbestos-associated disease
was seen in 1899 by Dr. H. Montague Murray, a phy-
sician at the Charing Cross Hospital in London. The
case was a man with marked dyspneaemployed foronly
12 years in the carding room of a recently established
asbestos factory. Death occurred a year later and, at
autopsy, fibers ofthe mineral were seen (together with
what wererecognized asasbestosbodieswhentheslides
were reviewed in 1970s). Nevertheless, there was no
special comment made that the dust to which exposure
had occurred was fibrous in nature (1). Nor was there
recognition that special potential toxicity that might be
associated with the fibrous nature ofthe dust, although
public health authorities responsible for maintenance of
hygienic precautions in workplaces were then aware of
excessively dusty conditions and worker complaints
(2,3), and it had been categorized by HM Factory In-
spectors in 1898 as one of the four most hazardous oc-
cupational dusts.
Thesepositions areeasilyunderstood. First, although
it was known, in general, that some dusts could be ex-
tremely toxic and others apparently benign, reasons for
such differences had not been worked out. Knife grind-
ers of Sheffield inhaled dust, as did bricklayers of
Manchesterandagriculturallaborers ofWales, buttheir
shorter span oflife demonstrated that there was some-
thingspecialaboutthedusttowhichthey wereexposed.
Gradually, however, the special role ofcrystalline silica
in the various dusts was deciphered, and was well es-
tablished in 1916 by the brilliant Milroy Lecture of E.
L. Collis (4-6). This impressive display ofthe power of
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occupationaltoxicologyandclinicalepidemiologyserved
to focus attention on quartz: so much so that the po-
tentialtoxicityofinorganicdustparticlesthereafterwas
generally gauged by their content ofrespirable quartz.
Emphasis on quartz did not prevent identification of
clinicaldiseaseassociatedwithasbestosfiberinhalation.
Such cases were seen by physicians among employees
ofthe growing asbestos industry. The first such case in
the medical literature was reported in 1924 by W. E.
Cooke. The Cooke case opened a new era, with the
observations detailed in the British Medical Journal.
A further description of the case was published in the.
same journal in 1927 (8), allowing the condition to be
named "pulmonary asbestosis." It stimulated wide dis-
cussion at the next meeting of the British Medical As-
sociation and attracted the attention ofthe Medical In-
spectors of Factories, who sought out other cases.
Further, with awareness of additional instances of ill-
ness amongworkers exposed to this dust, a survey was
undertaken of employees of one of the largest British
asbestosplants. Thefindingsledtogeneralappreciation
that an important pneumoconiosis, without appreciable
amounts of quartz, existed (9).
Among the new findings in the rapidly burgeoning
medical reports, two stood out. The first was pleural
disease, which was detailed in the 1924 and well illus-
trated in the 1927 description of Cooke's case and was
soon amplified by additional radiological descriptions.
This abnormality further separated asbestosis from the
other pneumoconiotic dust diseases, since pleural ab-
normalities were not a feature ofeither silicosis or coal
workers' pneumoconiosis. Second, the strikingly unu-
sual finding of ifiamentous structures, both uncoated
(understood tobeasbestosfibers) andcoated, againwas
unique. The coated structures occasioned a vigorousI. J. SELIKOFF
debate at first, since their initial identification did not
establish them as related to the mineral fibers inhaled
[Cooke even considered (10) that the "curious bodies"
might be organic in nature]. Soon, however, their sig-
nificance was clarified, with their designation changing
from "curious bodies" (11) to "asbestosis bodies" to "as-
bestos bodies" (12). Further, it was rapidly established
that their central core need not be an asbestos fiber,
but that other inorganic materials, ifthey were fibrous
in form, could also stimulate the tissue reactions that
produce a coating, and the term "pseudo-asbestos bod-
ies" (13) was used, later to be generalized as "ferrugi-
nous bodies" (14).
Thus, by the mid-1930s, a new pneumoconiosis was
medically established and unusual features agreed
upon. The disease was due to a fibrous dust, unrelated
to crystalline silica content, the pleural surfaces could
frequently beinvolved, and the scarringproduced could
be extremely damaging (pulmonary insufficiency), even
fatal. The next 30 years were marked by continuing
accumulation ofinformation concerningdisease hazards
associated with exposure to the dust, including the fact
that the particles were fibrous in form. Nevertheless,
the fact that we were dealing with fibers was not one
of the outstanding questions explored during this pe-
riod. Rather, scientific and medical studies were driven
by accumulating knowledge of the spectrum of disease
hazards. The initial finding of lung cancers among as-
bestos-exposed workers in 1935 (15,16) added impetus
as did the initial reports of pleural and peritoneal me-
sothelioma in the 1950s (17-19) with even greater em-
phasis stimulated by the reports of the frequency of
pleural mesothelioma and the fact that it could be pro-
duced by much lighter exposure (environmental, family
contact) than that which caused serious pulmonary and
pleural fibrosis (20,21). Moreover, data became avail-
able indicating that amuch larger number ofpeople had
been and were being exposed to asbestos (22), including
the many hundreds of thousands using asbestos prod-
ucts in their work, products which had been produced
by considerably fewer individuals in the factories in
which they were manufactured. The dimensions of the
problem were greatlyextended, qualitatively andquan-
titatively.
It was at this point that focus and attention were
added to the fibrous nature ofthe dust, for a very good
reason. Augmented control measures were being con-
sidered. Amongthem, abandonment ofthe toxic fibrous
dust was one of the options. But if this were to be
adopted, the question ofsubstitutes for asbestos had to
be simultaneously considered. What would replace as-
bestos? For many applications, these also had to be
fibrous in form. Some had already come into commercial
use, including manmade mineral fibers such as fibrous
glass and rock wool.* Inevitably, with the scientific in-
* It is a historic irony that the British Admiralty, after pioneering
the use of "cotton silicate" in the 1890s, recognized this manmade
inorganic fiber to present a potential health hazard and subsequently
changed to asbestos for thermal insulation.
formation that had been gathered from 1930 on, ques-
tions arose astowhetherthe substitutesmightnothave
toxicity similar to that of asbestos fibers.
This historical development was, in a sense, codified
and stated almost in a form of scientific challenge by
the observations and thesis of Merle Stanton in 1972
(23) when his experimental research, albeit limited, led
him to consider the possibility that small inorganic fi-
bers, in general, might be inherently toxic to tissues,
particularly with regard to carcinogenicity (mesothe-
lioma), and that the probability oftumor induction was
related to their fibrous form, with a gradient that pro-
duced greater and greater risk as the fibers became
longer and thinner.
The Stanton Hypothesis, 1989
Stanton's hypothesis has been and is being explored,
probed, and tested in many ways (24). Not unexpect-
edly, questions have been raised and inconsistencies
noted. These do not, however, in my opinion, make it
less fruitful as an overall guide to studies concerning
asbestos or for the evaluation ofotherinorganic fibrous
materials, particularly those that might be used as sub-
stitutes for asbestos. Rather, they serve to refine and
extend the overall concept.
Thus, Stanton's emphasis on the dimensions offibers
has been enriched by appreciation that chemical and
physical characteristics are also ofpotential importance
(25-27). For example, there has been increasing dis-
cussion concerning the possible different toxicities of
the various fiber types, if not for asbestosis and lung
cancer, then perhaps for mesothelioma; the "crocidolite
*hypothesis" (28)wasmodifiedtoan"amphibolehypothe-
sis" (29) which, in turn, has been further altered by
some to a "tremolite hypothesis" (30) to explain me-
sotheliomas seen in chrysotile-exposed individuals.
Further, discrepancies between results of studies of
fiber lung burdens and associated disease (31-33) have
begun to be explained by such wry observations as those
pointing to selective bias (34) perhaps almost inevitable
in providing lung specimens for analysis, and by Sebas-
tien's studies ofthe fiber burden ofpleura, when consid-
ering pleural mesothelioma. He did not limit analytical
measurements to what is in the pulmonary parenchyma,
especially since findings at the two sites differ substan-
tially, both quantitatively and qualitatively (35,36).
Additional modifications have been forthcoming as data
accumulate. For example, it seemed curious that mesoth-
eliomas were reported in humans for all the common as-
bestos fibers except anthophyllite, even though this type
of asbestos produced the neoplasm in animals and both
lung cancer and asbestosis in man. New work in Finland,
where much ofthe asbestos used has been anthophyllite,
now shows substantial levels of anthophyllite in individ-
uals with mesothelioma in that country (37).
Another unexplained observation was troubling. The
most physiological route of exposure in animal studies
was clearly by inhalation, yet few mesotheliomas were
soproduced. Incollectedseriesofmorethan600animals
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exposed to crocidolite by inhalation, only a handful of
mesotheliomas were seen. On the otherhand, the same
fiber type, with exposure by injection or implantation
into a mesothelial cavity, readily gave large numbers
of mesothelial tumors. Pott has astutely pointed this
out, noting that the nonphysiological route seemed
much more predictive ofmesothelioma potential in ex-
perimental studies than did physiological exposure, a
lesson that could be relevant in the investigation ofpos-
sible asbestos substitutes (38).
Additional discrepancies in the results of different
studies could be explained by the recent appreciation
that the standardized UICC asbestos materials (39)
used in many studies were by no means standardized,
in terns that would now be relevant, including trace
elements or the presence of contaminating asbestos fi-
bers other than those ofthe overall designation (chry-
sotile, amosite, crocidolite), as well as distribution of
fiber dimensions, features that might be relevant to
differences in experimental results. The UICC samples
were analyzed forthe tasks oftheirtime, butthey have
been evaluated since in ways not originally foreseen.
Asbestos Disease, 1989
It may be useful to consider several aspects of the
asbestos disease situation as research continues and ex-
pands into human fiber toxicity, particularly that po-
tentially associated with asbestos substitutes and re-
placements.
Spectrum ofAsbestos-Associated Disease
Adequate knowledge concerning the full dimensions of
human disease associated with asbestos exposure has
been hampered by a number of epidemiological con-
straints. The first is the size ofpopulations studied. Since
wegenerallycomparewhatisseenamongexposedgroups
with the same findings in unexposed groups (expected
rates), we need to have available sufficient experiences
to be able tojudge whether or not there is an increase in
incidence and whether that increase can be reliably said
to be present, from a statistical point ofview. This would,
of course, be particularly true for diseases of lesser fre-
quency. This constraint was very much in evidence in
Richard Doll's classic report in 1955 oflung canceramong
workers in the asbestos textile factory in which Cooke's
case was employed; there were only 39 deaths among the
113individuals beingfollowed (40). While thiswas enough
to identify a significant increase in lung cancer (11 cases
versus fewer thanx 1 expected) there were simply not
enough data to permit analysis of the incidence of other
asbestos-associated diseases, includingneoplasms ofother
sites. This difficulty exists in both clinical and mortality
studies, and is even more obvious in the mortality studies
because collection of series of deaths add the constraint
of adequate time of observation during which deaths
might occur.
A second governing problem is that of latency. The
first20years ofanymortalitystudyofasbestos-exposed
workers are unlikely to yield a sufficient number of
deaths to permit evaluation of a significant increase in
asbestos-associated deaths. In fact, the same difficulty
mightperhapsbe ascribed tothefirst25years or, even,
thefirst30years, ifthepopulation sizeisnotsufficiently
large and if the number of deaths, consequently, re-
mains relatively small.
Thus, we need to be able to observe the experiences
oflarge numbers ofexposed individuals for sufficiently
long periods of time. Practically, this translates into
person-years of observation of those whose exposure
began 25 or 30 or more years before.
Newdatahaverecentlybecomeavailablethatlargely
meet the two requirements outlined above. The mor-
tality experience of17,800 asbestos insulation workers,
the total membership of the International Association
of Heat and Frost Insulators and Asbestos Workers,
AFL-CIO, CLC in the United States and Canada, has
been observed prospectively from January 1, 1967 to
December 31, 1986. Four thousand nine hundred fifty-
one deaths were seen, with each subjected to clinical,
pathological, and demographic study. Causes of death
were ascertained in two ways: on the basis ofthe death
certificate designation (DC) andafterreviewofall avail-
able medical/pathological data (best evidence, BE). Ob-
served deaths were then compared with those expected
by cause, taking age, year, and sex into account, with
expected deaths calculated from deathrates ofthe U.S.
National Center for Health Statistics for white males,
1967 to 1986. The rationale for such an approach has
been discussed (41).
Table 1 illustrates that the principal diseases causing
death among asbestos-exposed workers remain those
already identified. This is true whether contrasts are
made between expected deaths (based upon death cer-
tificate data) and those recorded either on death certif-
icates ofthe workers involved or ascertained following
review of all available data. Expected deaths were
3450.5 and 4951 occurred. The principal cause of the
excess deaths was cancer (761.41 expected at all sites;
2127 were so recorded on death certificate and 2295
found to have been present after examination of avail-
able material). The major cancers involved were bron-
chogenic carcinoma (268.66 anticipated, 1168 observed
onbestevidence)mesothelioma (458occurred, although
nonewereexpected)andamodestincreaseinneoplasms
ofthegastrointestinaltract. Asbestosisalsowasamajor
cause of death, with 427 being seen.
A number of other cancers were increased in inci-
dence, but were by no means as numerous as lung can-
cer, mesothelioma, or gastrointestinal cancer. Table 2
provides information concerninga numberofthese (lar-
ynx, oropharynx and buccal cavity, kidney, pancreas,
gallbladder, andbile ducts). Onthe otherhand, various
other cancers were not observed in excess, including
lymphoma and leukemia and carcinoma of the ureter,
urinary bladder and prostate (Table 3).
Latency
Virtually no increases in death rates, either overall
or for specific diseases, were seen in the first 15 years
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Table 1. Deaths among 17,800 asbestos insulation workers in the United States and Canada, January 1, 1967 to December 31, 1986:
principal causes of death.
Observed deaths
Expected Death certificate Best evidenceb
Causes of death deathsa Number SMR Number SMR
All causes 3453.50 4951 143* 4951 143*
All cancer 761.41 2127 279* 2295 301*
Lung cancer 268.66 1008 375* 1168 435*
Pleural mesotheliomac 89 173
Peritoneal mesotheliomac 92 285
G.I. cancerd 135.69 188 139* 189 139*
G.I. cancer, extendede 191.66 324 169* 269 140*
Noninfectious respiratory disease 144.82 465 321* 507 350*
Asbestosisc 201 427
All other causes 2547.27 2359 93* 2149 84*
aExpected deaths based upon death rates 1967-1986 ofthe U.S. National Center for Health Statistics, for white males.
bAscertained after review ofautopsy, surgical and clinical material. Where no such data were available, death certificate diagnosis was used
except for mesothelioma. Cases were accepted for this diagnostic category only after Mount Sinai's histopathology review and confirmation.
cRates are not available since these have been rare causes of death in the general population.
d Includes cancer of stomach, esophagus, and colon/rectum.
eIncludes cancer of stomach, esophagus, colon/rectum, liver, gall bladder, and bile ducts.
*p < 0.001.
Table 2. Deaths among 17,800 asbestos insulation workers in the United States and Canada, January 1, 1967 to December 31, 1986:
less common asbestos-associated cancers.
Observed deaths
Expected Death certificate Best evidenceb
Cause of death deathsa Number Ratio Number Ratioc
Cancer of larynx 10.57 17 1.61 18 1.70*
Cancer of oropharynx 22.02 38 1.73t 48 2.18*
Cancer ofkidney 18.87 32 1.70t 37 1.96*
Cancer of pancreas 39.52 92 2.33t 54 1.37*
Cancer of esophagus 17.80 29 1.63* 30 1.68*
Cancer of stomach 29.36 34 1.16 38 1.29
Cancer of colon/rectum 88.49 125 1.41t 121 1.37t
Cancer ofgall bladder, bile ducts 5.37 13 2.42t 14 2.61t
aExpected deaths based upon death rates 1967-1986 ofthe U.S. National Center for Health Statistics, for white males.
bAscertained after review of autopsy, surgical and clinical material. Where no such data were available, death certificate diagnosis was used.
cCalculated for information only, since it used best evidence versus death certificate diagnoses, not strictly comparable due to different quality
of ascertainment and verification.
*p < 0.05.
tp < 0.01; range 0.010 but less than 0.050.
tp < 0.001; range 0.001 but less than 0.009.
Table 3. Deaths among 17,800 asbestos insulation workers in the United States and Canada, January 1, 1967 to December 31, 1986:
cancers not found with increased incidence.
Observed deaths
Expected Death certificate Best evidenceb
Cause of death deathsa Number Ratio Number Ratioc
Cancer of bladder 20.77 17 0.82 22 1.06
Cancer of prostate 52.56 59 1.12 61 1.16
Leukemia 28.74 32 1.11 33 1.15
Lymphoma 43.24 33 0.76 39 0.90
Melanoma (skin) 12.65 11 0.87 9 0.71
Brain tumors (all) 26.35 40 1.52* 3 1.25
Cancer 22.55 29 1.29 7 1.20
Cancer of liver 11.06 31 2.80t 12 1.00
aExpected deaths based upon death rates 1967-1986 of the U.S. National Center for Health Statistics, for white males.
bAscertained after review of autopsy, surgical, and clinical material. Where no such data were available, death certificate was used.
'Calculated for information only, since it used best evidence versus death certificate diagnoses, not strictly comparable due to different quality
of ascertainment and verification.
*p < 0.05.
tp < 0.001.
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after onset of exposure and comparatively little after
that until 25 or 30 years had passed. If the same were
tobetruefordiseasethatmight beassociated withman-
made mineral fibers, for example, the first 30 years of
observation of cohorts of individuals exposed to such
fibers would provide little information with regard to
potential neoplastic toxicity; epidemiologically, such in-
formation would constitute empty data. Figures 1 and
2 depict the incidence of deaths of asbestosis and per-
itoneal mesothelioma following onset ofwork exposure.
Parenthetically, if we were to truncate epidemiol-
ogical mortality studies ofasbestos-exposed workers at
age 65, a practice sometimes recommended for cancer
studies in general, it would be difficult to fully appre-
ciate the importance oflatency in the evaluation ofthe
incidence of asbestos-associated cancer. Figures 3 and
4 indicate that approximately one-third ofthe deaths of
mesothelioma, for example, occurred after age 65.
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With growing awareness of the hazards of asbestos
exposure, searching inquiries have been directed be-
yond previously studied populations such as mining and
milling, product manufacturing, shipyards, insulation
work, brake repair and brake lining, family contact and
neighborhood disease, etc. The numerical scope of the
problem has been considerably expanded by recent in-
vestigations ofasbestos-associated disease among such
diverse groups as railroad workers (42-44), merchant
marine seamen (45,46), as well as a variety ofconstruc-
tion trades, custodians and building maintenance work-
ers, power production and public utilities, and main-
tenance and repair in a wide variety ofsituations. Still
incompletely quantified populations are being added to
the more than 10 million survivors of the 27,500,000
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FIGURE 1. Deaths ofasbestosis among asbestos insulation workers
in the United States and Canada, 1967 to 1986.
FIGURE 3. Ages at death of asbestos insulation workers in the
United States and Canada who died from pleural mesothelioma,
1967 to 1986.
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FIGURE 2. Deaths from peritoneal mesothelioma among asbestos
insulation workers in the United States and Canada, 1967 to 1986.
FIGURE 4. Ages at death of asbestos insulation workers in the
United Statesand Canadawhodiedfromperitonealmesothelioma,
1967 to 1986.
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workers previously enumerated in 10 of the most im-
portant asbestos-exposure trades, considered signifi-
cantly exposed from 1940 to 1979 by Nicholson and his
colleagues (47).
The building industry is ofparticular importance, not
only because of the large number of workers who en-
tered the various construction trades from 1950to 1970,
and therefore very much at risk of asbestos-associated
cancerdeathforthenext40yearsorso, butalsobecause
of the continued exposure of construction workers as
they do maintenance and repair work in buildings and
facilities still laden with asbestos installed in previous
years. Recent studies have shown significant propor-
tions of workers in such diverse trades as sheetmetal,
pipefitting, plumbing, drywall construction, painting,
carpentry, and electrical work to have radiological evi-
dence of asbestotic abnormalities in clinical surveys.
(48-50).
Research Perspectives Derived from
Asbestos Experience
The unhappy experience with asbestos provides not
only the stimulus for examination of potential toxicity
of other fibers but perhaps useful general guidelines to
their clinical and epidemiological evaluation. We know
a good deal about the spectrum ofdisease with at least
this one group of fibrous minerals (as well as with the
zeolite, erionite) and, although different neoplasms and
different diseases might well occur with otherinorganic
fibers that have been and will be proposed as asbestos
replacements, there is a good chance that investigation
ofthe increased incidence of the asbestos cancers will
be helpful in evaluating substitutes for toxicity to hu-
mans. Too, it is likely that the same sort of latency is
involved (with concordant age distribution) and there
may even be such multiple factor interaction as that
seen between asbestos and cigarette smoking (51,52).
Nevertheless, study of potential human toxicity of
substitutes, while very important, is perhaps inade-
quate. Additionally, prevention of disease should be a
concern, from the beginning. In this, I would include
not merely primary prevention (avoidance ofexposure)
but secondary prevention of disease even should sub-
stantial exposure sometimes occur (perhaps inevitable
if a substance is to be used at all).
Prevention of Clinical Disease among
Those Exposed to Asbestos and Other
Inorganic Fibers
Disease following asbestos exposure is notinevitable.
Experience has shown us that even with significant ex-
posure, not all individuals develop an asbestos-associ-
ated cancer or disabling asbestosis. Reasons for such
differences in susceptibility have been but little ex-
plored (53); for example, we have few data concerning
the significance ofimmunomodification not infrequently
seen among asbestos-exposed workers. Similarly, a va-
riety ofbiological phenomena have been observed that
may contain fertile hints with regard to differences in
susceptibility. The lower frequency of disease in solid
organs comes to mind (although some such disease is
seen, as in pancreas and kidney, we do not see it in
spleen, bone, muscle, prostate, liver, brain, or regional
lymph nodes). Is this simply a reflection of different
dose/response relationships, or a basic biological phe-
nomenon? Epithelial surfaces seemparticularlyaffected
(respiratory tract, gastrointestinal), but this is not uni-
versally true. Although asbestos fibers are found in the
urine of asbestos-exposed workers (52) and although
kidney cancer is increased, we do not see similar in-
creases in cancer of the ureter, bladder, or prostate.
Erionite gives the same tumors (and pleural and pa-
renchymal fibrosis) amongexposed residents ofthe zeo-
lite areas in Turkey, yet the fibers are physically and
chemically distinct from asbestos varieties, albeit sim-
ilar in their dimensions. Although asbestos fibers are
transported across the placental barrier, mesothelioma
ininfants bornto asbestos-exposed women has notbeen
reported eitherat birth orinearlylife. Forlungcancer,
there may be important differences between small cell
and nonsmall cell cancers, yet in asbestos-exposed
workers, all cell types are seen, in the same frequency
as in lung cancer in general. Further, some asbestos-
exposed workers not only develop one or another ofthe
asbestos cancers, but may have multiple primaries in,
for example, the lung or stomach, as well as cancer
known to be associated with asbestos exposure in other
organs. Yetotherindividuals, withapparentlythe same
exposure, develop no cancer, or only one at a single
cancer site. Are these biological differences due to var-
iations among individuals or to the nature ofexposure?
Reversal of Risk
Is it possible to reverse at least some of the risk
amongthose already exposed toinorganic fibers? There
is some evidence thatthis maybe possible. First, it was
reportedin 1979(54)thatasbestosworkerswhostopped
smoking, after 5 to 10 years, have approximately one-
half to one-third the risk of dying of lung cancer com-
pared to similar asbestos workers who continue to
smoke cigarettes. Of course, this may be related not
only to diminution of fiber risk but to the previously
identified decrease inriskofdeath oflungcanceramong
cigarette smokers in general who stopped smoking.
Some additional, more direct, evidence has recently
become available, the result of what almost may be
termed a large-scale natural experiment. When, in 1964,
the serious cancer and pneumoconiosis risk of asbestos-
exposed insulation workers was reported (22), both the
labor unions and many employers began to use at least
the most obvious control measures. While these were by
no means always rigorous, they did serve to begin to
decrease asbestos exposure on the job. Such diminution
was accelerated and amplified in 1972 and 1973 when as-
bestos was no longer included in newly manufactured in-
sulation materials in the United States. This served to
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further decrease exposure, although some continued dur-
ing repair and maintenance work involving previously in-
stalled asbestos-containing insulation materials.
In the 20-year prospective study that was begun in
1967, we therefore had occasion to evaluate death rates
in three periods of times: before removal of asbestos
from new insulation materials (but with some use of
better industrial hygiene precautions) (1967-1972);
shortly after the removal of asbestos from these ma-
terials (1973-1979), and some years following removal
(1980-1986). We have analyzed death rates for the ma-
jor asbestos-associated diseases (asbestosis, broncho-
genic carcinoma, pleural and peritoneal mesothelioma)
for each of these three periods, comparing duration-
from-onset categories. The data indicate that reduction
inexposure had ameasurable effect indecreasingdeath
rates for asbestosis, bronchogenic carcinoma, and per-
itoneal mesothelioma, at least for those in the mid-pe-
riodfromonset(55). After40yearsfromonset, reducing
exposure did not seem to make any difference, nor was
therereduction indeathratesforpleuralmesothelioma,
even in the mid-period. These data indicate that reduc-
tion of exposure can be important in reducing risks for
some individuals already exposed.
Preclinical Diagnosis
Clinical diagnosis of cancer, even when early in the
course of disease that has appeared, is therapeutically
disadvantaged-diagnosis is not early, in biological
terms. The possibility exists that ifthe diagnosis could
beestablished beforeclinicalabnormalityappears, man-
agement, including chemotherapy, might be more suc-
cessful.
At one time, it was hoped that cytological evidence of
neoplastic change, as in bronchial secretions, could serve
this purpose in high risk asbestos-exposed groups. This
has not proven to be the case (56). There has therefore
been interest in identifying predlinical diagnostic ap-
proaches, perhaps cytological or immunological. An ob-
vious candidate has been mesothelioma, derived from
what is, in a sense, a specific tissue, with fairly unique
histochemical and immunocytochemical features. Roboz
and colleagues have undertaken experimental studies us-
ing transplanted human mesothelial tissue in the nude
mouse and have found increasing concentrations of hy-
aluronic acid as the tumor grows (57). Whether this will
prove to be useful for asbestos-exposed individuals being
monitored for the development of pleural or peritoneal
mesothelioma may be a suitable subject forinvestigation.
Molecular Epidemiology
Considering the wide agreement concerning the like-
lihood of a multistage process in the development of
human cancer, it may well prove useful to investigate
whether the sequential molecular changes in that pro-
cess can be identified (58). Ifthis is found to be the case,
it would naturally follow that investigations could be
undertaken to see whether the sequence of changes
leading to clinical cancer could be interrupted.
Ordinarily, it would be extremely difficult to inves-
tigate this attractive hypothesis, in view ofthe random
nature of most neoplastic disease and the absence of
knowledge concerning who might be at risk. With as-
bestos exposure, however, it might be feasible. Large
populations of asbestos-exposed individuals have been
identified. In many instances, these individuals are
available for prospective surveillance, including a va-
riety of tests that would explore molecular changes of
the carcinogenic process that is under way. It is even
conceivablethathumangenetherapy(replacement, cor-
rection, oraugmentation) couldbeconsidered (59). Such
prospective studies ofdefined populations at risk would
be anappropriate extension ofthe epidemiological stud-
ies that have been accomplished to this point.
REFERENCES
1. Murray, H. M. Report of Departmental Committee on Compen-
sation for Industrial Diseases. Minutes ofevidence, CD3946 Her
Majesty's Stationery Office, London, 1907, pp. 127-128.
2. Chief Inspector of Factories and Workshops for the Year 1898.
Annual report on the work of HM women inspectors. Her Maj-
esty's Stationery Office, London, 1899, pp. 170-172.
3. Chief Inspector of Factories and Workshops. Annual Report,
1899. Her Majesty's Stationery Office, London, 1900, p. 264.
4. Collis, E. L., Milroy Lecture, 1915. Industrial pneumoconiosis,
with special reference to dust-phthisis. Public Health (London)
28: 252-264 (1915).
5. Collis, E. L. Milroy Lecture, 1915. Industrial pneumoconiosis,
with special reference to dust-phthisis. Public Health (London)
29: 11-20 (1915).
6. Collis, E. L. Milroy Lecture, 1915. Industrial pneumoconiosis,
with special reference to dust-phthisis. Public Health (London)
29: 37-44 (1915).
7. Cooke, W. E. Fibrosis of the lungs due to the inhalation of as-
bestos dust. Br. Med. J. 2: 147 (1924).
8. Cooke, W. E. Pulmonary asbestosis. Br. Med. J. 2: 1024-1025
(1927).
9. Merewether, E. R. A., and Price, C. V. Report on Effects of
Asbestos Dust on the Lungs and Dust Suppression in the As-
bestos Industry. Her Majesty's Stationery Office, London, 1930.
10. Cooke, W. E., and Hill, C. F. Pneumoconiosis due to asbestos
dust. J. R. Micro. Soc. 47 (Series III): 232-238 (1927).
11. Gloyne, S. R. A method of staining the asbestosis bodies found
in the sputum ofasbestos workers. J. Ind. Hyg. 13: 85-86 (1931).
12. Gloyne, S. R. The formation of the asbestos body in the lung.
Tubercle 12: 399-401 (1931).
13. Tylecote, F. E., and Dunn, J. S. Case of asbestos-like bodies in
the lungs of a coal-miner who had never worked in asbestos.
Lancet ii: 632-633 (1931).
14. Gross, P., Cralley, L. J., and de Treville, R. T. P. Asbestos
bodies: their non-specificity. Am. Ind. Hyg. Assoc. J. 28: 541-
542 (1967).
15. Lynch, K. M., and Smith, W. A. Pulmonary asbestosis. Carci-
noma of the lung in asbesto-silicosis. Am. J. Cancer 24: 56-64
(1935).
16. Gloyne, S. R. Two cases of squamous carcinoma of the lung oc-
curring in asbestosis. Tubercle 17: 5-10 (1935).
17. Weiss, A. Pleurakrebs bei lungenasbestose, in vivo morpholo-
gisch gesichert. Medizinische 1: 93-94 (1953).
18. Leicher, F. Primary mesothelioma of peritoneum in a case of
asbestosis. Arch. Gewerbepath. 13: 382-392 (1954).
19. Konig, J. Uber die asbestose. Arch. Gewerbepath. 18: 159-204
(1960).
20. Wagner, J. C., Sleggs, C. A., and Marchand, P. Diffuse pleural276 I. J. SELIKOFF
mesothelioma in the North Western Cape Province. Br. J. Ind.
Med. 17: 260-271 (1960).
21. Newhouse, M. L., and Thompson, H. Mesothelioma ofpleura and
peritoneum following exposure to asbestos in the London area.
Br. J. Ind. Med. 22: 261-269 (1965).
22. Selikoff, I. J., Churg, J., and Hammond, E. C. Asbestos exposure
and neoplasia. J. Am. Med. Assoc. 188: 22-26 (1964).
23. Stanton, M. F., and Wrench, C. Mechanisms of mesothelioma
induction with asbestos and fibrous glass. J. Natl. Cancer Inst.
48: 797-821 (1972).
24. Harington, J. S. Fibercarcinogenesis: epidemiologic observations
and the Stanton hypothesis. J. Natl. Cancer Inst. 67: 977-989
(1981).
25. Bignon, J., and Jaurand, M. C. Reaction du poumon profond a
l'inhalation de fibres minerales. C. R. Soc. Biol. 174: 479-487
(1980).
26. Jaurand, M. C., Bastie-Sigeac, I., Renier, A., and Bignon, J.
Comparativetoxicities ofdifferentformsofasbestosonratpleural
mesothelial cells. Environ. Health Perspect. 51: 153-158 (1983).
27. Beck, E. C., and Bignon, J., Eds. Invitroeffects ofmineraldusts.
In: Third International Workshop, Vol.3. Published in coopera-
tion with NATO ASI Series, Series G. Springer-Verlag, 1985,
pp. 548.
28. Wagner, J. C. Asbestos cancers. J. Natl. Cancer Inst. Monogr:
52: 41-46 (1979).
29. Wagner,J. C., Pooley, F. D., Berry, G., Seal, R. M. E., Mundlay,
D. E., Morgan, J., and Clark, N. J. A pathological and miner-
alogical study ofasbestos-related deaths in the United Kingdom
in 1977. Ann. Occup. Hyg. 26: 423-431 (1982).
30. Churg, A. Chrysotile, tremolite, and malignant mesothelioma in
man. Chest 93: 621-628 (1988).
31. Gylseth, B., Churg, A., Davis, J., Johnson, N., Morgan, R.,
Mowe, G., Rogers, A., and Roggli, V. Analysis ofasbestos fibers
and asbestos bodies in tissue samples from human lung. Scand.
J. Work Environ. Health 11: 107-110 (1985).
32. Warnock, M. L., and Wolery, G. Asbestos bodies or fibers and
the diagnosis of asbestosis. Environ. Res. 44: 29-44 (1987).
33. Pooley, F. D., and Ranson, D. L. Comparison of the results of
asbestos fibre dust counts in lung tissue obtained by analytical
electronmicroscopyandlightmicroscopy. J. Clin. Pathol. 39:313-
317 (1986).
34. McDonald, J. C. Letter to the Editor. Tremolite, other amphi-
boles, and mesothelioma. Am. J. Ind. Med. 14: 247-249 (1989).
35. Sebastien, P.,Janson, X., Gaudichet, A., Hirsch, A., andBignon,
J. Asbestos retention in human respiratory tissues: comparative
measurements in lung parenchyma and in parietal pleura. In:
Biological Effects ofMineral Fibers, Vol. 1 (J. C. Wagner, Ed.),
IARC Scientific Publications, Lyon, France, 1980, pp. 237-246.
36. Viallat, J. R., Raybaud, F., Passeral, M., and Boutin, C. Pleural
migration ofchrysotile fibers after intratracheal injection in rats.
Arch. Environ. Health 41: 282-286 (1986).
37. Tuomi, T., Segerberg-Konttinen, Margaretha, Tammilehto, L.,
Tossavainen, A., and Vanhala, E. Mineral fiber concentration in
lungtissue ofmesothelioma patients in Finland. Am. J. Ind. Med.
16: 247-254 (1989).
38. Pott, F., Bellmann, B., Muhle, H., Rodelspeiger, K. Intraperi-
toneal injection studies for the evaluation of the carcinogenicity
of fibrous phyllosilicates. In: Proceedings of the First Interna-
tional Conference on Health-Related Effects of Phyllosilicates,
Paris, March 16-18, 1989, in press.
39. Harington, J. S. The U.I.C.C. standard samples. A review after
25 years, submitted.
40. Doll, R., Mortality from lung cancer in asbestos workers. Br. J.
Ind. Med. 12: 81-86 (1955).
41. Selikoff, I. J., Hammond, E. G., and Seidman, H. Mortality ex-
perience ofasbestos insulation workers in the United States and
Canada. Ann. N.Y. Acad. Sci. 330: 91-116 (1979).
42. Oliver, L. C., Eisen, E. A., Green, R. E., and Sprince, N. L.
Asbestos-related disease in railroad workers: a cross-sectional
study. Am. Rev. Respir. Dis. 131: 499-504 (1985).
43. Mancuso, T. F. Mesothelioma among machinists in railroad and
other industries. Am. J. Ind. Med. 4: 501-513 (1983).
44. Mancuso, T. F. Relative risk of mesothelioma among railroad
machinists exposed to chrysotile. Am. J. Ind. Med. 13: 639-657
(1988).
45. Selikoff, I. J., Lilis, R., and Levin, G. Asbestotic radiological
abnormalities amongUnited States merchant marine seamen. Br.
J. Ind. Med., in press.
46. Velonakis, E. G., Tsorva, A., Tzonou, A., and Trichopoulos, D.
Asbestos-related chest X-ray changes in Greek merchant marine
seamen. Am. J. Ind. Med. 3: 259-311 (1982).
47. Nicholson, W. J., Perkel, G., and Selikoff, I. J. Occupational
exposure to asbestos: population at risk and projected mortality,
1980-2030. Am. J. Ind. Med. 3: 259-311 (1982).
48. Baker, E. L., Dagg, T., and Greene, R. E. The significance of
asbestos-associated pleural disease among sheet metal workers.
J. Occup. Med. 27: 483-489 (1985).
49. Oliver, L. C., Eisen, E. A., Greene, R., and Sprince, N. L.
Asbestos-related pleural plaques and lung function. Am. J. Ind.
Med. 14: 649-656 (1988).
50. Rosenstock, L., and Hudson, L. D. The pleural manifestations
of asbestos exposure. Occup. Med. State Art Rev. 2: 383-404
(1987).
51. Selikoff, I. J., Hammond, E. C., and Churg, J. Asbestos expo-
sure, smoking and neoplasia. JAMA 204: 106-112 (1968).
52. Hammond, E. C., Selikoff, I. J., and Seidman, H. Asbestos ex-
posure, cigarette smoking and death rates. Ann. N.Y. Acad. Sci.
330: 473-490 (1979).
53. Lynch, H. T., and Hirayama, T., Eds. Genetic Epidemiology of
Cancer. CRC Press, Boca Raton, FL, 1989, p. 3.
54. Wyss, V. Presenza diaghi di amianto nelle urine di operai espositi
al rischio asbestico. Rass. Med. Ind. (22-23): 55-56 (1953-1954).
55. Seidman, H., and Selikoff, I. J. Death rates ofinsulation workers
in the United States and Canada: modification after decrease of
asbestos exposure. Ann. N.Y. Acad. Sci., in press.
56. Kotin, P., and Paul, W. Results of early lung cancer detection
programs. Recent Res. Canc. Res. 82: 131-137 (1982).
57. Roboz, J., Chahinian, P., Holland, J. F., Silides, D., and Szrajer,
L. Early diagnosis and monitoring oftransplanted human malig-
nant mesothelioma by serum hyaluronic acid. J. Natl. Cancer
Inst. 81: 924-928 (1989).
58. Selikoff, I. J. Breaking the iron grip oflatency, in press.
59. Friedmann, T. Progress toward human gene therapy. Science
244: 1275-1281 (1989).